ClinicalTrials.Veeva

Menu

ChatGPT-Supported Text Messaging Program for Smoking Cessation

George Washington University (GW) logo

George Washington University (GW)

Status

Not yet enrolling

Conditions

Smoking Cessation

Treatments

Behavioral: BeFree
Behavioral: BeFree+Bot

Study type

Interventional

Funder types

Other

Identifiers

NCT07079306
GWUniversity

Details and patient eligibility

About

The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and BeFree.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • lives in the US
  • smoked a cigarette within the last 7 days
  • has a mobile phone
  • willing to receive text messages about the health effects of smoking on their mobile phone for 30 days

Exclusion criteria

  • none

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

150 participants in 2 patient groups

Intervention
Experimental group
Description:
Text messages about quitting smoking and access to specialized ChatGPT chatbot
Treatment:
Behavioral: BeFree+Bot
Control
Active Comparator group
Description:
Text messages about quitting smoking
Treatment:
Behavioral: BeFree

Trial contacts and locations

1

Loading...

Central trial contact

Lorien Abroms, ScD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems